Render Target: STATIC
Render Timestamp: 2024-11-21T13:40:04.763Z
Commit: 5c4accf06eb7154018ba3f54329c7590f97f534a
XML generation date: 2024-09-20 06:22:59.369
Product last modified at: 2024-09-20T07:03:30.626Z
1% for the planet logo
PDP - Template Name: Growth Factors and Cytokines
PDP - Template ID: *******9ad1159

Mouse RANKL/TRANCE/TNFSF11 Recombinant Protein #68495

    Product Information

    Storage

    Mouse RANKL/TRANCE/TNFSF11 Recombinant Protein is supplied as lyophilized material that is very stable at -20°C. It is recommended to reconstitute with sterile water at a concentration of 0.1 mg/ml which can be further diluted in aqueous solutions as needed. Addition of a carrier protein (0.1% HSA or BSA) is recommended for long-term storage.

    Once in solution, store at 4°C and use within 1 month, or store at -20ºC to -80ºC and use within 3 months to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles if storing reconstituted material at -20ºC to -80ºC.

    Product Description

    MW (kDa) 19
    Purity A greater than or equal to 95% purity was determined by SDS-PAGE.
    Endotoxin Endotoxin levels are less than or equal to 1 EU / 1 μg mRANKL.
    Activity The bioactivity of recombinant mRANKL was determined in a secreted embryonic alkaline phosphatase (SEAP) induction assay using RAW-Blue™ cells. The ED50 of each lot is less than or equal to 50 ng/ml. RAW-Blue™ Cells were purchased from InvivoGen Inc. 

    Source / Purification

    Recombinant mouse RANKL was expressed in E. coli and is supplied in a lyophilized form. This product was produced without any FBS or animal-derived ingredients.

    Background

    RANKL, also known as TRANCE, TNFSF11, or OPGL, is a member of the TNF superfamily of ligands. T cells, mammary epithelial cells, and endothelial cells can produce RANKL (1). RANKL is expressed as a type II transmembrane protein or cleaved into a soluble form by extracellular proteases, such as TACE, ADAM10, and matrix metalloproteases (1). Alternative splicing also results in the production of soluble RANKL (1). RANKL signaling is antagonized by osteoprotegerin, which functions as a soluble decoy receptor (2). RANKL plays key roles in mammary gland development and dendritic cell survival and is required for osteoclast differentiation and survival (3-6). Research studies have shown that RANKL deficiencies in both mice and humans are associated with abnormally increased bone density and defects in lymphoid organogenesis (5,6).
    For Research Use Only. Not For Use In Diagnostic Procedures.
    Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.
    All other trademarks are the property of their respective owners. Visit our Trademark Information page.